Trial intelligence / Profile preview

SODA study of sofosbuvir + daclatasvir with or without ribavirin in chronic hepatitis C

NL-OMON44573Phase 3Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Nov 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 3 trial of sofosbuvir, daclatasvir, ribavirin in hepatitis C virus infection, sponsored by Amsterdam University Medical Center. Started Nov 2014; status: active, not recruiting.

02

Drugs

sofosbuvirdaclatasvirribavirin
03

Conditions

hepatitis C virus infection

Beyond the preview

Go deeper on NL-OMON44573.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON44573.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call